In conclusion, our results have demonstrated that overexpression of the splicing factor NONO promotes GBM progression, and the inhibition of NONO leads to intron retention in GPX1. The decrease in GPX1 induced apoptosis and inhibition of invasion due to an increase in ROS. This evidence concerns the gene GPX1 and glioblastoma.